Search and analyze individual stocks with comprehensive metrics
Murae Organisor Ltd
Fundamental Score
Murae Organisor Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of MURAE across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Attractive Valuation (P/E: 3.77 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Robust Profit Growth (3200.00%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (1634.78%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (73.03% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Strong Profit Growth Track Record (32.81% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
8 factors identified
Below-Average Return on Equity (5.69%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (4.20%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (-0.18%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Elevated Debt Levels (D/E: 1.02)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability and cash flow generation.
Negative Free Cash Flow (₹-343.64 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Loading Peer Comparison
Finding companies in the Pharmaceuticals sector...
Financial Statements
Comprehensive financial data for Murae Organisor Ltd
About MURAE
Business Overview
Murae Organisor Limited engages in the trade in agriculture activities in India. The company was formerly known as Earum Pharmaceuticals Limited and changed its name to Murae Organisor Limited in November 2023. Murae Organisor Limited was incorporated in 2012 and is based in Ahmedabad, India.
Company Details
Key Leadership
Latest News
MURAE Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Murae Organisor Ltd (MURAE)?
As of 16 Jan 2026, 10:13 am IST, Murae Organisor Ltd (MURAE) is currently trading at ₹0.24. The stock has a market capitalization of ₹57.26 (Cr).
Is MURAE share price Overvalued or Undervalued?
MURAE is currently trading at a P/E ratio of 3.77x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Murae Organisor Ltd share price?
Key factors influencing MURAE's price include its quarterly earnings growth (Sales Growth: 1634.78%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Murae Organisor Ltd a good stock for long-term investment?
Murae Organisor Ltd shows a 5-year Profit Growth of 32.81% and an ROE of 5.69%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 1.02 before investing.
How does Murae Organisor Ltd compare with its industry peers?
Murae Organisor Ltd competes with major peers in the Pharmaceuticals. Investors should compare MURAE's P/E of 3.77x and ROE of 5.69% against the industry averages to determine its competitive standing.
What is the P/E ratio of MURAE and what does it mean?
MURAE has a P/E ratio of 3.77x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹4 for every ₹1 of annual earnings.
How is MURAE performing according to Bull Run's analysis?
MURAE has a Bull Run fundamental score of 47.4/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does MURAE belong to?
MURAE operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Murae Organisor Ltd.
What is Return on Equity (ROE) and why is it important for MURAE?
MURAE has an ROE of 5.69%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Murae Organisor Ltd generates profits from shareholders' equity.
How is MURAE's debt-to-equity ratio and what does it indicate?
MURAE has a debt-to-equity ratio of 1.02, which indicates high leverage that increases financial risk. A ratio below 1.0 generally indicates conservative financing.
What is MURAE's dividend yield and is it a good dividend stock?
MURAE offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has MURAE grown over the past 5 years?
MURAE has achieved 5-year growth rates of: Sales Growth 73.03%, Profit Growth 32.81%, and EPS Growth 12.83%.
What is the promoter holding in MURAE and why does it matter?
Promoters hold 0.00% of MURAE shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is MURAE's market capitalization category?
MURAE has a market capitalization of ₹57 crores, placing it in the Small-cap category.
How volatile is MURAE stock?
MURAE has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for MURAE?
MURAE has a 52-week high of ₹N/A and low of ₹N/A.
What is MURAE's operating profit margin trend?
MURAE has a 5-year average Operating Profit Margin (OPM) of -0.18%, indicating the company's operational efficiency.
How is MURAE's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 1634.78% and YoY Profit Growth of 3200.00%.
What is the institutional holding pattern in MURAE?
MURAE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.